🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Plant bling: cellulose that sparkles nature.com/articles/s4158…

New online in Nature Biotechnology: An optical pooled screening method can correlate phenotypes and perturbations in any nucleated cell type. Caroline Fandrey, Marius Jentzsch, Jonathan Schmid-Burgk

A method for designing high-affinity, specific binders to peptide–MHC complexes may improve the next generation of antigen-specific T cell-based therapeutics #NBTNV go.nature.com/3ZFVH0O rdcu.be/d3ZBW

New online in Nature Biotechnology: A strategy for combinatorial cancer immunotherapy uses Cas13d to knock down immunosuppressive genes in vivo—by Feifei Zhang, Ryan Chow Guangchuan Wang Sidi Chen et.al.

The brief digital edition of our Nature Biotechnology January issue is live as well! Check it out here mp.weixin.qq.com/s/GIMh7TzIznLM…

New online in Nature Biotechnology: Lipid nanoparticles carrying plasmid DNA and an inflammation inhibitor enable longer transgene expression than mRNA nanoparticles-by Manthan , Jacob S. Brenner et al.

New online in Nature Biotechnology: Primary T cells with multiple genetic modifications are rapidly isolated by negative selection. Chris Chang Brian Shy Justin Eyquem

The brief digital edition of our March issue is live as well! Check it out here mp.weixin.qq.com/s/5MDvA1JHC0Qi…

Check out the state of the field of engineered bacteria for cancer therapy in this Comment in Nature Biotechnology nature.com/articles/s4158…

The April issue is live, with a focus on cancer immunotherapy nature.com/nbt/volumes/43… On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ

Spotlight on cancer immunotherapies go.nature.com/3XUTPkM

Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in Nature Biotechnology and don't forget to check out our full Focus Issue! nature.com/articles/s4158…

The development of therapeutic cancer vaccines is seeing exciting progress recently. Curious how researchers are dealing with challenges to translate new technologies to the clinic? Nature Biotechnology asked experts for an update. nature.com/articles/s4158…

The brief digital edition of our 2025 Cancer Immunotherapy Focus Issue is live as well! Check it out here: mp.weixin.qq.com/s/i5t1sfgpL-YF…

Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y rdcu.be/eh1qR

The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT rdcu.be/eiiow

A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat nytimes.com/2025/05/15/hea…

The May issue is live nature.com/nbt/volumes/43… On the cover, a platform for template-independent enzymatic synthesis of RNA oligonucleotides using reversible terminator nucleoside triphosphates that offers a sustainable alternative to traditional methods go.nature.com/3zBfDZf

The brief digital edition of our May issue is live now! Check it out here: mp.weixin.qq.com/s/Ph75nRcl02Hk…

Fruit waste for catwalk fashion nature.com/articles/s4158…